You just read:

Enzyvant's Investigational Regenerative Treatment (RVT-802) for Congenital Athymia to be Discussed in Symposium, Platform Presentation and Poster Session at Clinical Immunology Society Meeting

News provided by

Enzyvant

Apr 03, 2019, 07:00 ET